Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I C Marschner

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3D M Wall, R Sparrow, X F Hu, et al.
Journal of the American College of Cardiology|July 14, 2001
Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study InvestigatorsI C Marschner, D Colquhoun, R J Simes, et al.
The Journal of Infectious Diseases|February 1, 1995
Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in IndonesiaT A Ruff, D M Gertig, B F Otto, et al.
The New England Journal of Medicine|October 29, 1998
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 TeamD V Havlir, I C Marschner, M S Hirsch, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.
Statistics in Medicine|November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshopJ M Albert, J P Ioannidis, P Reichelderfer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)H-M Lin, T Scheinberg, N Portman, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3D M Wall, R Sparrow, X F Hu, et al.
Journal of the American College of Cardiology|July 14, 2001
Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study InvestigatorsI C Marschner, D Colquhoun, R J Simes, et al.
The Journal of Infectious Diseases|February 1, 1995
Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in IndonesiaT A Ruff, D M Gertig, B F Otto, et al.
The New England Journal of Medicine|October 29, 1998
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 TeamD V Havlir, I C Marschner, M S Hirsch, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.
Statistics in Medicine|November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshopJ M Albert, J P Ioannidis, P Reichelderfer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)H-M Lin, T Scheinberg, N Portman, et al.
Pageof 3